Congestive heart failure affects as many as 5 million Americans and with an aging population, more than half a million patients are diagnosed with the condition each year.
During an average life span of 70 years, the human heart will pump more than 400 million litres of blood.
While most people are familiar with the big-name heart problems such as cardiac arrest and congestive heart failure, PAD is often overlooked.
The company’s first product is a low-profile “Stent-On-a-Wire” system that reduces the number of steps involved in the stenting procedure.
Blood-thinning drug Plavix racks up over $8 billion in annual sales, but the blockbuster medication may have some new competition.
Symphony Medical, a developer of novel biopolymer technologies for cardiac disorders, has successfully used its flagship Algisyl-LVR technology to treat their first human patient.
Copyright © 2024 | WordPress Theme by MH Themes